[1]
2020. LGALS3 +191A and +292C polymorphisms are associated with a reduction in serum gal-3 levels, but not with the clinical events of individuals with sickle cell anemia. Research, Society and Development. 9, 9 (Aug. 2020), e442997314. DOI:https://doi.org/10.33448/rsd-v9i9.7314.